Formulation Development and Evaluation of Colon Targeting Nanosponges of Deflazacort Using Box Behnken Design
Sarvesh Mishra, Neeraj Sharma, Shailesh Jain
Journal of Pharmaceutical Research International · pp. 451–459 · Published 29 Dec 2021
10.9734/jpri/2021/v33i63A35961Abstract
Deflazacort is a glucocorticoid that is often used as an anti-inflammatory and immunosuppressant for patients suffering from Inflammatory Bowel Disease such as ulcerative colitis (UC) and Crohn's disease (CD). IBD is difficult to manage, and the most difficult issue for doctors is the recurrence. There are several regulated and colon focused medication delivery devices available for therapy, however they have a low success rate. The goal of this work was to create nanosponges loaded with deflazacort using the quasi-emulsion solvent diffusion technique using Eudragit S-100 and to investigate the influence of process factors on response using the Box-Behnken design. The effect of three independent parameters, Eudragit S100, PMMA, and PVA, on two dependent responses, particle size and percent drug entrapment, was investigated. Using the Box-behnken design, seventeen nanosponge formulations were created using the quasi-emulsion solvent diffusion technique and Eudragit S-100 (0.2 percent to 0.5 percent w/v), PMMA (0.2 percent to 0.5 percent w/v), and PVA (0.5 percent -1.5 percent w/v). Particle size, percent drug entrapment, shape and surface morphology, drug content determination, and in vitro drug release behaviour were all evaluated in the nanosponge formulations. The generated nanosponge was virtually spherical in form and spongy in character, with particle size 170.45 nm and a drug entrapment percentage of 73.42 percent. Over a 24-hour period, in vitro drug release of optimised formulations was shown to have a maximum drug release of 90.33.3 percent in colonic fluid with 4 percent w/v caecal content. The observed values of several assessment parameters were found to be in close agreement with the projected values using the Design expert programme. The nanosponge formulation obtained using Eudragit S-100 in low concentration, optimum concentration ratio of eudragit: PVA along with low stirring speed showed desired features. The mathematical models were further designed to develop nanosponge with required characteristics.
Cited by 7
Vineeth Bharadwaj. P, Vinayak Mastiholimath, Atith Muppayyanamath · BioNanoScience · 2025
Preety Gautam, Md Habban Akhter, Anubhav Anand · Biomedical Materials · 2024
Jaymin Patel, Kaushika Patel, Shreeraj Shah · Research Journal of Pharmacy and Technology · 2024
Showing 3 of 7 known citations — external sources report more than can currently be individually listed.
Related research
- Optimization of the Production of α-L-Rhamnosidase by Aspergillus niger in Solid State Fermentation Using Agro-Industrial Residues — shares topic coverage
- Response Surface Optimization of Bath Type Ultrasound-Assisted Extraction (UAE) of Native Starch from Fresh Cassava Tubers — shares topic coverage
- Application of Box-Behnken Design for the Optimized Production of Lactic Acid by Newly Isolated Lactobacillus plantarum JX183220 Using Cassava (Manihot esculenta Crantz) Flour — shares topic coverage
- Application of Box-Behnken Design for the Optimization of Citric Acid Production from Corn Starch Using Aspergillus niger — shares topic coverage
- Empirical Modelling and Optimization of Ngbo Pillarred Activated Clay Catalysts using Response Surface Methodology — shares topic coverage
Article metrics
Real usage data collected on this platform.
3
Page views
0
PDF downloads
0
Outbound clicks
7
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.